NCT00531557View on ClinicalTrials.gov

Double Protease Inhibitor to Darunavir Switch Study

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HIV Infections
Interventions
DRUG

Darunavir ritonavir

Trial Locations (1)

Unknown

St Stephens Centre, Chelsea & Westminster Hospital, London

All Listed Sponsors
lead

St Stephens Aids Trust

OTHER

NCT00531557 - Double Protease Inhibitor to Darunavir Switch Study | Biotech Hunter | Biotech Hunter